Trials / Completed
CompletedNCT03723265
Personalized CRT - PSR
Personalized CRT - Product Surveillance Registry (PSR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,517 (actual)
- Sponsor
- Medtronic · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.
Detailed description
The Personalized CRT study is a multi-center, single arm, prospective observational study. The purpose of the study is to better understand and characterize heart failure (HF) patient management by characterizing the use and clinical benefit of Medtronic market-released features/tools within the HF Patient Management portfolio.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac Resynchronization Therapy |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2022-04-28
- Completion
- 2022-04-28
- First posted
- 2018-10-29
- Last updated
- 2022-05-20
Locations
122 sites across 13 countries: United States, Belgium, Canada, France, Germany, Italy, Malaysia, Netherlands, Serbia, South Korea, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT03723265. Inclusion in this directory is not an endorsement.